Status | Study |
Completed |
Study Name: A Clinical Trial Assessing Safety of MF101 for Hot Flushes Condition: Hot Flashes Date: 2011-02-16 Interventions: Drug: MF101 MF101 10 g/day MF101 15 g/day Other Name |
Completed |
Study Name: Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial Condition: Hot Flashes Date: 2011-02-10 Interventions: Behavioral: Hypnosis Hypnosis |
Completed |
Study Name: Evaluation of SAMe for Hot Flashes Condition: Healthy, no Evidence of Disease Hot Flashes Date: 2010-06-08 Interventions: Drug: S-adenosyl-L-methionine disulfate p-toluene-sulfonate |
Active, not recruiting |
Study Name: Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors Condition: Hot Flashes Date: 2009-10-29 Interventions: Drug: Gabapentin Use of Gabapentin as a control intervention to evaluate the relative effects and advers |
Withdrawn |
Study Name: Venlafaxine and Hypnosis or Focused Attention In Treating Patients With Hot Flashes Condition: Hot Flashes Date: 2009-10-19 Interventions: Drug: venlafaxine Given orally |
Completed |
Study Name: Stellate Ganglion Nerve Block in Treating Women With Hot Flashes Condition: Hot Flashes Date: 2009-04-08 Interventions: Drug: bupivacaine hydrochloride Other: que |
Completed |
Study Name: Breathe for Hot Flashes Randomized Controlled Trial Condition: Hot Flashes Date: 2009-01-07 Interventions: Behavioral: Paced respiration |
Completed |
Study Name: Pregabalin in Treating Women With Hot Flashes Condition: Breast Cancer Hot Flashes Date: 2008-06-19 Interventions: Drug: pregabalin Given orally |
Completed |
Study Name: Understanding Experimentally Induced Hot Flushes Condition: Hot Flashes Date: 2007-04-02 Interventions: Drug: Leuprolide acetate (Lupron) Leuprolide acetate (Lupr |
Completed |
Study Name: Skin Conduction Device for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes Condition: Hot Flashes Date: 2007-01-25 Interventions: Other: physiologic testing |